Background Previous systematic reviews have not shown clear benefit of glucocorticoids for
acute viral bronchiolitis, but their use remains considerable. Recent large trials add …

Respiratory syncytial virus (RSV) infection has an estimated global incidence of 33 million
cases in children younger than 5 years, with 10% requiring hospital admission and up to …

Background An increased prevalence of asthma/recurrent wheeze (RW), clinical allergy and
allergic sensitisation up to age 13 years has previously been reported in subjects …

Respiratory syncytial virus (RSV) infection is a major cause of respiratory illness in infants
and the elderly. Although several vaccines have been developed, none have succeeded in …

Respiratory syncytial virus (RSV) is an exceptional mucosal pathogen. It specializes in
infection of the ciliated respiratory epithelium, causing disease of variable severity with little …

Objective To examine the timing and duration of RSV bronchiolitis hospital admission
among term and preterm infants in England and to identify risk factors for bronchiolitis …

Bronchiolitis is the most common reason for admission to hospital in the first year of life.
There is tremendous variation in the clinical management of this condition across Canada …

Aim Bronchiolitis is the most common lower respiratory tract disorder in infants aged less
than 12 months, and research has demonstrated that there is substantial variation in practice …

Epinephrine for bronchiolitis - Hartling, L - 2011 | Cochrane Library Skip to Content Cookies
Our site uses cookies to improve your experience. You can find out more about our use of …

Asthma remains an important human disease that is responsible for substantial worldwide
morbidity and mortality. The causes of asthma are multifactorial and include a complex mix …